The Scripps Research Institute (TSRI) on Monday announced the appointment of chemist Peter G. Schultz as CEO and biologist Steve A. Kay as president.
Schultz is currently a member of the TSRI faculty, as well as director of the California Institute for Biomedical Research (Calibr). He also is a successful entrepreneur and has led major drug discovery efforts in both the commercial and nonprofit sectors.
Kay, a former TSRI faculty member, is currently dean of the Dornsife Coll...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In